TITLE

Coeliac disease: in vivo toxicity of the putative immunodominant epitope

AUTHOR(S)
Fraser, J. S.; Engel, W.; Ellis, H. J.; Moodie, S. J.; Pollock, E. L.; Wieser, H.; Ciclitira, P. J.
PUB. DATE
December 2003
SOURCE
Gut;Dec2003, Vol. 52 Issue 12, p1698
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Peptides from α-gliadins have been used to characterise the immunodominant coeliac toxic epitope. A peptide corresponding to amino acid residues 57-73 of A-gliadin causes peripheral blood mononuclear cells from coeliac patients to secrete interferon γ (IFN-γ); gluten specific small intestinal T cell clones proliferate in response to peptides corresponding to residues 57-68 and 62-75 of α-gliadins. We wished to investigate whether a peptide corresponding to residues 56-75 of α-gliadins exacerbates coeliac disease in vivo. Methods: Four adults with coeliac disease, all of whom were on a gluten free diet, underwent three challenges. Peptic-tryptic gliadin (PTG 1 g) served as a positive control. The test peptide and a negative control peptide were studied on separate occasions. The peptides were instilled into the duodenum and biopsies were taken before the infusion, and two, four, and six hours after commencing the infusions, using a Quinton hydraulic multiple biopsy capsule. Biopsy specimens were assessed blindly for villus height to crypt depth ratio (VH:CD), enterocyte cell height (ECH), and intraepithelial lymphocyte (IEL) count. We used the Mann-Whitney U test, with 95% confidence intervals, for statistical analysis. Results: VH:CD and ECH fell, and IEL increased significantly 4-6 hours after commencing infusions with both PIG and the test peptide in all subjects. The negative control peptide caused no significant changes to villus morphology, enterocyte height, or IEL count in any patient. Conclusion: We have confirmed that the putative immunodominant epitope, a peptide corresponding to residues 56-75 of α-gliadins, exacerbates coeliac disease in vivo.
ACCESSION #
12940906

 

Related Articles

  • Citrulina plasmática como marcador de pérdida de masa enterocitaria en la enfermedad celíaca en la infancia. Blasco Alonso, J.; Serrano Nieto, J.; Navas López, V. M.; Barco Gálvez, A.; Vicioso, I.; Carazo Gallego, B.; Ortiz Pérez, P.; Sierra Salinas, C. // Nutricion Hospitalaria;jul/ago2011, Vol. 26 Issue 4, p807 

    Introduction: Plasma citrulline is not incorporated in endogenous or exogenous proteins so it is a theoretical marker of villous atrophy. Our aim was to correlate plasma citrulline levels with severity of villous atrophy in celiac patients. Methods: Observational case-control study longitudinal...

  • Gliadin Peptides Activate Blood Monocytes from Patients with Celiac Disease. JANA CINOVA; LENKA PALOVÁ-JELÍNKOVÁ; MARIE ČERNÁ; BARBARA PECHAROVÁ; MILOS DVOŘÁK; PAVEL FRUHAUF; HELENA TLASKALOVÁ-HOGENOVÁ; LUDMILA TUČKOVÁ // Journal of Clinical Immunology;Mar2007, Vol. 27 Issue 2, p201 

    To elucidate the role of innate immune responses in celiac disease, we investigated the effect of gliadin on blood monocytes from patients with celiac disease. Gliadin induced substantial TNF-? and IL-8 production by monocytes from patients with active celiac disease, lower levels by monocytes...

  • Different binding motifs of the celiac disease-associated HLA molecules DQ2.5, DQ2.2, and DQ7.5 revealed by relative quantitative proteomics of endogenous peptide repertoires. Bergseng, Elin; Dørum, Siri; Arntzen, Magnus; Nielsen, Morten; Nygård, Ståle; Buus, Søren; Souza, Gustavo; Sollid, Ludvig // Immunogenetics;Feb2015, Vol. 67 Issue 2, p73 

    Celiac disease is caused by intolerance to cereal gluten proteins, and HLA-DQ molecules are involved in the disease pathogenesis by presentation of gluten peptides to CD4 T cells. The α- or β-chain sharing HLA molecules DQ2.5, DQ2.2, and DQ7.5 display different risks for the disease. It...

  • The HLA-DRB4 gene does not explain genetic susceptibility in HLA-DQ2-negative celiac disease. Partanen, Jukka // Immunogenetics;Mar2000, Vol. 51 Issue 3, p249 

    Evaluates the role of the DRB4 gene in genetic susceptibility to Celiac disease (CD). Association of CD with the presence of the HLA-DQA1; Evidence supporting that the HLA-DRB4 gene does not explain genetic susceptibility in HLA-DQ2-negative celiac disease; Analysis on the distribution of...

  • Local Challenge on Oral Mucosa With an α-Gliadin Related Synthetic Peptide in Patients With Celiac Disease. Lähteenoja, Hannu; Mäki, Markku; Viander, Markku; Räihä, Ismo; Vilja, Pekka; Rantala, Immo; Toivanen, Auli; Syrjänen, Stina // American Journal of Gastroenterology;Oct2000, Vol. 95 Issue 10, p2880 

    OBJECTIVE: Gluten-derived peptides (e.g., amino-acids 31-49 of α-gliadin) have been shown to cause changes typical of celiac disease in the gut. Gluten-derived peptides have mostly been used in in vitro studies. The easiest access to the gastrointestinal system may be the mouth. In...

  • Editorial. van Rensburg, Christo // South African Gastroenterology Review;Apr2014, Vol. 12 Issue 1, p1 

    An introduction to the journal is presented in which the guest editors discuss complex issue of coeliac's disease (CD).

  • Symptom Finder: Celiac Disease. Bidwell, Rebecca // Baby Talk;Sep2001, Vol. 66 Issue 7, p21 

    Focuses on celiac disease, an allergy to glutten. Consequence if the condition is untreated; Symptoms and diagnosis, Treatment.

  • Gluten sensitivity: a many headed hydra. Hadjivassiliou, M.; Grunewald, R. A.; Davies-Jones, G. A. B. // BMJ: British Medical Journal (International Edition);06/26/99, Vol. 318 Issue 7200, p1710 

    Editorial. Focuses on coeliac disease or gluten sensitivity enteropathy. History of the treatment of coeliac disease; Association between neurological disorders and adult coeliac disease; Typical clinical manifestation of a patient with gluten sensitivity.

  • Celiac disease comes in many disguises. Donohue, Paul G. // Adirondack Daily Enterprise;7/14/2010, Vol. 117 Issue 165, p6 

    The article provides an answer to a question related to celiac disease.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics